nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical Universitynefr-95Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESНовые маркеры в диагностике люпус-нефрита у детей (обзор литературы)New markers in the diagnostics of lupus nephritis in children (literature review)КозыроИ. А.KazyraI. A.kozyroia@mail.ruСукалоА. В.SukaloA. V.noemail@neicon.ruБелорусский государственный медицинский университетРоссияBelarus State Medical UniversityRussian Federation2015010520151933943Copyright © Козыро И.А., Сукало А.В., 20152015Козыро И.А., Сукало А.В.Kazyra I.A., Sukalo A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/95

В обзоре литературы представлены современные знания о новых маркерах, применяемых для диагностики и мониторинга активности волчаночного нефрита у детей, что может быть использовано в практической работе педиатра-нефролога для оптимизации проводимого лечения и определения его продолжительности.

Review presents the present knowledge of the new markers for diagnostics and monitoring the activity of lupus nephritis in children, which can be used in practice of pediatric-nephrologist to optimize the treatment and determine its duration.

люпус-нефритдетиантителацитокинымикро-РНКlupus nephritischildrenantibodiescytokinesmicro-RNAsReferencesLehman Thomas J.A., Mouradian Janet A. Systemic Lupus Erythematosus. In: T.M. Barratt, E.D. Avner, W.E. Harmon. Pediatric Nephrology, 4th ed. Pennsylvania: Lippincott Williams&Wilkins. 1999; 793-810Lehman Thomas J.A., Mouradian Janet A. Systemic Lupus Erythematosus. In: T.M. Barratt, E.D. Avner, W.E. Harmon. Pediatric Nephrology, 4th ed. Pennsylvania: Lippincott Williams&Wilkins. 1999; 793-810Salgado A., Herrera-Diaz C. Lupus nephritis: an overview of recent findings. Autoimmune disease. 2012; Article ID 849684: 21Salgado A., Herrera-Diaz C. Lupus nephritis: an overview of recent findings. Autoimmune disease. 2012; Article ID 849684: 21Jordan N., Lutalo P.M., D’Cruz D.P. Novel therapeutic agents in clinical development for Systemic Lupus Erythematosus. BMC Medicine. 2013; 3 11(1): 120Jordan N., Lutalo P.M., D’Cruz D.P. Novel therapeutic agents in clinical development for Systemic Lupus Erythematosus. BMC Medicine. 2013; 3 11(1): 120Niaudet P., Salomon R. Systemic Lupus Erythematosus. In: E.D. Avner, W.E. Harmon, P. Niaudet. Pediatric Nephrology, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2004; 865-886Niaudet P., Salomon R. Systemic Lupus Erythematosus. In: E.D. Avner, W.E. Harmon, P. Niaudet. Pediatric Nephrology, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2004; 865-886Rees L. In L. Rees, N. Webb, P. Brogan. Paediatric nephrology, London: Oxford University Press, 2007; 282-296Rees L. In L. Rees, N. Webb, P. Brogan. Paediatric nephrology, London: Oxford University Press, 2007; 282-296Avramescu C., Biciusca V., Daianu T. et al. Cytokine panel and histopathological aspects in the systemic lupus erythematosus. Romanian journal of Morphology and Embryology. 2010; 51(4): 633-640Avramescu C., Biciusca V., Daianu T. et al. Cytokine panel and histopathological aspects in the systemic lupus erythematosus. Romanian journal of Morphology and Embryology. 2010; 51(4): 633-640Brunner H.I., Bennett M.R., Mina R. et al. Association of nonin-vasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum. 2012; 64(8): 2687-2697Brunner H.I., Bennett M.R., Mina R. et al. Association of nonin-vasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum. 2012; 64(8): 2687-2697Edelbauer M., Kshirsagar S., Riedl M. et al. Markers of childhood lupus nephritis indicating disease activity. Pediatr. Nephrol. 2011; 26: 401-410Edelbauer M., Kshirsagar S., Riedl M. et al. Markers of childhood lupus nephritis indicating disease activity. Pediatr. Nephrol. 2011; 26: 401-410Vachvanichsanong P., McNeil E. Pediatric lupus nephritis: more options, more chances? Lupus. 2013; 22(6): 545-553Vachvanichsanong P., McNeil E. Pediatric lupus nephritis: more options, more chances? Lupus. 2013; 22(6): 545-553Watson L., Beresford M. Urine biomarkers in juvenile-onset SLE nephritis. Pediatr. Nephrol. 2013; 28(3): 363-374Watson L., Beresford M. Urine biomarkers in juvenile-onset SLE nephritis. Pediatr. Nephrol. 2013; 28(3): 363-374Vincent F.B., Saulep-Easton D., Feggett W.A. et al. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev. 2013; 24(3): 203-215Vincent F.B., Saulep-Easton D., Feggett W.A. et al. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev. 2013; 24(3): 203-215Hammad A., Mosaad Y., Elhanbly S. et al. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children. Lupus 2013; 22(5): 486-491Hammad A., Mosaad Y., Elhanbly S. et al. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children. Lupus 2013; 22(5): 486-491Yang C.C., Hsieh S.C., Li K.J. et al. Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus. J Biomed Biotechnol. 2012; In press. DOI: 10.1155/2012/759313Yang C.C., Hsieh S.C., Li K.J. et al. Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus. J Biomed Biotechnol. 2012; In press. DOI: 10.1155/2012/759313Hinze C.H., Suzuki M., Klein-Gitelman M. et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 2009; 60(9): 2772-2781Hinze C.H., Suzuki M., Klein-Gitelman M. et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 2009; 60(9): 2772-2781Lorenzen J.M., Haller H., Thum T. MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol. 2011; 7(5): 286-294Lorenzen J.M., Haller H., Thum T. MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol. 2011; 7(5): 286-294Wang G., Tam L.S., Kwan B.C. et al. Serum and urinary free microRNA level in patients with SLE. Lupus 2011; 20(5): 493-500Wang G., Tam L.S., Kwan B.C. et al. Serum and urinary free microRNA level in patients with SLE. Lupus 2011; 20(5): 493-500Wang G., Kwn B.C., Lai F. et al. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Disease Markers. 2010; 28: 79-86Wang G., Kwn B.C., Lai F. et al. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Disease Markers. 2010; 28: 79-86Cмирнов А.В., Карунная А.В., Зарайский М.И. и др. Экспрессия микроРНК-21 в моче у пациентов с нефропатиями. Нефрология 2014; 16(6): 59-63 [A.V. Smirnov, A.I. Karunnaja, M.I. Zarajskij, i dr. Jekspressija mikroRNK-21 v moche u pacientov s nefropatijami. Nefrologija 2014; 18(6): 59-63]Cмирнов А.В., Карунная А.В., Зарайский М.И. и др. Экспрессия микроРНК-21 в моче у пациентов с нефропатиями. Нефрология 2014; 16(6): 59-63 [A.V. Smirnov, A.I. Karunnaja, M.I. Zarajskij, i dr. Jekspressija mikroRNK-21 v moche u pacientov s nefropatijami. Nefrologija 2014; 18(6): 59-63]

The authors declare that there are no conflicts of interest present.